H. Lundbeck A/S Intends to Appeal the Decision From the European Commission

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Valby, Denmark, 19 June 2013 - H. Lundbeck A/S (Lundbeck) today received the European Commission’s decision that the company’s agreements concluded with four generic competitors concerning citalopram violated competition law. The decision, that Lundbeck intends to appeal, includes fining Lundbeck EUR 93 million (approximately DKK 700 million).

Help employers find you! Check out all the jobs and post your resume.

Back to news